Why it was recalled
Subpotent drug
Product description
Mometasone Furoate Ointment USP, 0.1%, 15 g tubes, Rx Only, Manufactured by Perrigo, Yeruham 80500, Israel, Distributed by Perrigo, Allegan, MI 49010, NDC 45802-0119-37
Lot numbers, UPCs & expiration codes
Lot # 063630, Exp 04/16; 069793, Exp 11/16; 071745, Exp 02/17; 076150, Exp 07/17; 081317, Exp 12/17
Where it was sold
Nationwide and Puerto Rico
What to do if you have this product
- Compare the lot number and expiration date on your package with the codes above.
- Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
- If you have symptoms you think are related, contact your doctor. In an emergency call 911.
- Report side effects to FDA MedWatch at 1-800-FDA-1088.
Recall details
- Recall number
- D-1286-2015
- Classification
- Class III
- Status
- Terminated
- Recall initiated
- Jul 13, 2015
- FDA report date
- Aug 12, 2015
- Quantity
- 158,268 tubes
- Recall type
- Voluntary: Firm initiated
- Recalling firm
- Perrigo Israel Pharmaceuticals
Original FDA data
Every field from FDA enforcement report D-1286-2015, exactly as published.
Show all FDA fields
- City
- Yeruham
- Status
- Terminated
- Country
- Israel
- Event ID
- 71765
- Address
- 1 Zvi Bornstein Rd
- Code information
- Lot # 063630, Exp 04/16; 069793, Exp 11/16; 071745, Exp 02/17; 076150, Exp 07/17; 081317, Exp 12/17
- Report date
- Aug 12, 2015
- Product type
- Drugs
- Recall number
- D-1286-2015
- Classification
- Class III
- Recalling firm
- Perrigo Israel Pharmaceuticals
- Product quantity
- 158,268 tubes
- Termination date
- Feb 11, 2016
- Reason for recall
- Subpotent drug
- Voluntary / mandated
- Voluntary: Firm initiated
- Product description
- Mometasone Furoate Ointment USP, 0.1%, 15 g tubes, Rx Only, Manufactured by Perrigo, Yeruham 80500, Israel, Distributed by Perrigo, Allegan, MI 49010, NDC 45802-0119-37
- Distribution pattern
- Nationwide and Puerto Rico
- Recall initiation date
- Jul 13, 2015
- Initial firm notification
- Letter
- Center classification date
- Aug 5, 2015